MPLT (STOCKS)
MapLight Therapeutics, Inc. Common Stock
$28.820000
-0.390000 (-1.34%)
Prev close: $29.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher A. Kroeger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,232.52M
- Employees
- 133
- P/E (TTM)
- -6.38
- P/B (TTM)
- 3.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.34 | $-1.12 | -0.2247 | -20.15% |
|
Dec 2025 (Q4)
|
$-2.47 | $-0.98 | -1.4888 | -151.73% |
|
Sep 2025 (Q3)
|
$-37.18 | $-1.76 | -35.4205 | -2,013.10% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $210.04M |
| Research and Development | $172.25M |
| Other Operating Expenses | $37.80M |
| Operating Income/Loss | -$210.04M |
| Income/Loss From Continuing Operations After Tax | -$199.48M |
| Income/Loss From Continuing Operations Before Tax | -$199.48M |
| Net Income/Loss | -$199.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$199.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$199.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $9.43 |
| Diluted Earnings Per Share | $9.43 |
| Basic Average Shares | 53,195,906 |
| Diluted Average Shares | 53,195,906 |
| Assets | $418.79M |
| Current Assets | $327.23M |
| Noncurrent Assets | $91.56M |
| Fixed Assets | $968.00K |
| Other Non-current Assets | $90.59M |
| Liabilities | $18.95M |
| Current Liabilities | $14.28M |
| Accounts Payable | $3.19M |
| Wages | $2.21M |
| Other Current Liabilities | $8.88M |
| Noncurrent Liabilities | $4.67M |
| Equity | $399.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $399.83M |
| Liabilities And Equity | $418.79M |
| Net Cash Flow From Operating Activities | -$163.77M |
| Net Cash Flow From Operating Activities, Continuing | -$163.77M |
| Net Cash Flow From Investing Activities | -$293.70M |
| Net Cash Flow From Investing Activities, Continuing | -$293.70M |
| Net Cash Flow From Financing Activities | $463.02M |
| Net Cash Flow From Financing Activities, Continuing | $463.02M |
| Net Cash Flow | $5.55M |
| Net Cash Flow, Continuing | $5.55M |
| Comprehensive Income/Loss | -$200.45M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$200.45M |
| Other Comprehensive Income/Loss | -$200.45M |